Table I.
Mean age and 1-year outcomes in contemporary trials focusing on revascularization strategy of STEMI patients with MVD
| Trial | Pts | Groups | Age (mean ± SD) | Outcome in the culprit-only arm |
||
|---|---|---|---|---|---|---|
| MI | Revascularization | MACE | ||||
| COMPLETE17 | 4041 | Angio/FFR complete vs culprit only | 62 ± 11 | 7.9%⁎ | 7.9%⁎ | 16.7%⁎ |
| COMPARE-ACUTE15 | 885 | FFR complete vs culprit only | 62 ± 10 | 4.7% | 17.5% | 20.5% |
| CvLPRIT13 | 296 | Angio-complete vs culprit only | 65 ± 12 | 2.7% | 8.2% | 21.2% |
| DANAMI-3 PRIMULTI14 | 627 | FFR complete vs culprit only | 64 ± 10 | 5% | 9% | 22% |
| Politi et al16 | 214 | Angio-complete vs culprit only | 65 ± 12 | 8.3% | 33.3% | 50% |
| PRAMI12 | 465 | Angio-complete vs culprit only | 62 ± 10 | 8.6% | 19.9% | 22.9% |
| Dambrink et al51 | 121 | FFR complete vs culprit only | 62 ± 10 | 0%† | 22%† | 22%† |
| Hamza et al52 | 100 | Angio-complete vs culprit only | 54 ± 11 | 4%† | 12%† | 24%† |
| Di Mario et al53 | 69 | Angio-complete vs culprit only | 64 ± 10 | 6% | 35% | 35% |
Pts, number of patients.
⁎
At 3 years.
†
At 6 months.